

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.30093600 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.30093600 |
| 3 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.08012062 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.98420804 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.98420804 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.86198076 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.73767813 |
| 8 | protein carboxylation (GO:0018214) | 5.53904127 |
| 9 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.53904127 |
| 10 | complement activation, alternative pathway (GO:0006957) | 5.30325029 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.23158532 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.23158532 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.23158532 |
| 14 | urea cycle (GO:0000050) | 5.14337626 |
| 15 | urea metabolic process (GO:0019627) | 5.14337626 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.13313961 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.12749993 |
| 18 | negative regulation of interleukin-12 production (GO:0032695) | 5.12373014 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.09563539 |
| 20 | regulation of protein activation cascade (GO:2000257) | 5.04804505 |
| 21 | kynurenine metabolic process (GO:0070189) | 5.04391263 |
| 22 | tryptophan metabolic process (GO:0006568) | 4.98978945 |
| 23 | regulation of fibrinolysis (GO:0051917) | 4.90656898 |
| 24 | positive regulation of heat generation (GO:0031652) | 4.88277637 |
| 25 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.84102212 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.81230055 |
| 27 | glyoxylate metabolic process (GO:0046487) | 4.80877540 |
| 28 | regulation of complement activation (GO:0030449) | 4.79402100 |
| 29 | regulation of vitamin metabolic process (GO:0030656) | 4.79013258 |
| 30 | regulation of mononuclear cell migration (GO:0071675) | 4.73513237 |
| 31 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.73445419 |
| 32 | regulation of fever generation (GO:0031620) | 4.72645996 |
| 33 | plasma lipoprotein particle clearance (GO:0034381) | 4.70723814 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 4.69854601 |
| 35 | regulation of chronic inflammatory response (GO:0002676) | 4.67517473 |
| 36 | response to peptidoglycan (GO:0032494) | 4.67324853 |
| 37 | sulfur amino acid catabolic process (GO:0000098) | 4.64874838 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.60727045 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.58516091 |
| 40 | cysteine metabolic process (GO:0006534) | 4.58427259 |
| 41 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.46160448 |
| 42 | regulation of podosome assembly (GO:0071801) | 4.43492759 |
| 43 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.40460971 |
| 44 | reverse cholesterol transport (GO:0043691) | 4.39793572 |
| 45 | bile acid metabolic process (GO:0008206) | 4.39538139 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.35270199 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.35270199 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.35270199 |
| 49 | regulation of chemokine biosynthetic process (GO:0045073) | 4.28396366 |
| 50 | phospholipid efflux (GO:0033700) | 4.26665658 |
| 51 | regulation of cholesterol esterification (GO:0010872) | 4.25268757 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.22774507 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.22774507 |
| 54 | homocysteine metabolic process (GO:0050667) | 4.22546189 |
| 55 | serine family amino acid catabolic process (GO:0009071) | 4.18550681 |
| 56 | tyrosine metabolic process (GO:0006570) | 4.15844178 |
| 57 | aromatic amino acid family metabolic process (GO:0009072) | 4.11254684 |
| 58 | fibrinolysis (GO:0042730) | 4.10491073 |
| 59 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 4.10145421 |
| 60 | amino-acid betaine metabolic process (GO:0006577) | 4.10100650 |
| 61 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.09042632 |
| 62 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.02721190 |
| 63 | cholesterol efflux (GO:0033344) | 4.02139027 |
| 64 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.96151302 |
| 65 | aldehyde catabolic process (GO:0046185) | 3.94184123 |
| 66 | negative regulation of sterol transport (GO:0032372) | 3.83011774 |
| 67 | negative regulation of cholesterol transport (GO:0032375) | 3.83011774 |
| 68 | monocyte chemotaxis (GO:0002548) | 3.80901888 |
| 69 | alpha-amino acid catabolic process (GO:1901606) | 3.80430401 |
| 70 | positive regulation of lipid catabolic process (GO:0050996) | 3.79711172 |
| 71 | glycosphingolipid catabolic process (GO:0046479) | 3.77369752 |
| 72 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.77124951 |
| 73 | low-density lipoprotein particle clearance (GO:0034383) | 3.76851629 |
| 74 | cellular glucuronidation (GO:0052695) | 3.76166138 |
| 75 | bile acid and bile salt transport (GO:0015721) | 3.75747470 |
| 76 | lysine catabolic process (GO:0006554) | 3.75050884 |
| 77 | lysine metabolic process (GO:0006553) | 3.75050884 |
| 78 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.73706656 |
| 79 | myeloid dendritic cell differentiation (GO:0043011) | 3.73455868 |
| 80 | macrophage activation involved in immune response (GO:0002281) | 3.73405719 |
| 81 | low-density lipoprotein particle remodeling (GO:0034374) | 3.72881761 |
| 82 | regulation of heat generation (GO:0031650) | 3.71380708 |
| 83 | indolalkylamine metabolic process (GO:0006586) | 3.70514792 |
| 84 | plasma lipoprotein particle assembly (GO:0034377) | 3.69052145 |
| 85 | regulation of interferon-alpha production (GO:0032647) | 3.67774998 |
| 86 | T-helper 1 type immune response (GO:0042088) | 3.67582967 |
| 87 | amine catabolic process (GO:0009310) | 3.65918016 |
| 88 | cellular biogenic amine catabolic process (GO:0042402) | 3.65918016 |
| 89 | opsonization (GO:0008228) | 3.65144944 |
| 90 | oligosaccharide catabolic process (GO:0009313) | 3.65037906 |
| 91 | phospholipid homeostasis (GO:0055091) | 3.63736015 |
| 92 | coenzyme catabolic process (GO:0009109) | 3.63610978 |
| 93 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.61412091 |
| 94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.61412091 |
| 95 | cofactor catabolic process (GO:0051187) | 3.60003886 |
| 96 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.54420575 |
| 97 | NIK/NF-kappaB signaling (GO:0038061) | 3.53103933 |
| 98 | complement activation (GO:0006956) | 3.52915362 |
| 99 | cellular ketone body metabolic process (GO:0046950) | 3.52857171 |
| 100 | virion attachment to host cell (GO:0019062) | 3.52754174 |
| 101 | adhesion of symbiont to host cell (GO:0044650) | 3.52754174 |
| 102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.52728932 |
| 103 | imidazole-containing compound metabolic process (GO:0052803) | 3.52373494 |
| 104 | protein activation cascade (GO:0072376) | 3.52285086 |
| 105 | type I interferon signaling pathway (GO:0060337) | 3.49634870 |
| 106 | cellular response to type I interferon (GO:0071357) | 3.49634870 |
| 107 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.49414971 |
| 108 | glucuronate metabolic process (GO:0019585) | 3.49114672 |
| 109 | uronic acid metabolic process (GO:0006063) | 3.49114672 |
| 110 | cellular amino acid catabolic process (GO:0009063) | 3.48905900 |
| 111 | plasma lipoprotein particle organization (GO:0071827) | 3.48635530 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.48039720 |
| 113 | ethanol oxidation (GO:0006069) | 3.47564475 |
| 114 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.45597275 |
| 115 | benzene-containing compound metabolic process (GO:0042537) | 3.44935234 |
| 116 | response to type I interferon (GO:0034340) | 3.44908671 |
| 117 | sterol homeostasis (GO:0055092) | 3.44601027 |
| 118 | arginine metabolic process (GO:0006525) | 3.44347503 |
| 119 | protein-lipid complex assembly (GO:0065005) | 3.42818190 |
| 120 | germinal center formation (GO:0002467) | 3.42536972 |
| 121 | acute-phase response (GO:0006953) | 3.40593022 |
| 122 | complement activation, classical pathway (GO:0006958) | 3.40236708 |
| 123 | glycine metabolic process (GO:0006544) | 3.40224062 |
| 124 | lipoprotein metabolic process (GO:0042157) | 3.39715306 |
| 125 | cellular modified amino acid catabolic process (GO:0042219) | 3.38682138 |
| 126 | blood coagulation, intrinsic pathway (GO:0007597) | 3.38661959 |
| 127 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.37466680 |
| 128 | glycolipid catabolic process (GO:0019377) | 3.36661093 |
| 129 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.36094987 |
| 130 | neutrophil activation involved in immune response (GO:0002283) | 3.35895837 |
| 131 | protein-lipid complex subunit organization (GO:0071825) | 3.34720112 |
| 132 | response to protozoan (GO:0001562) | 3.34452112 |
| 133 | positive regulation of hemostasis (GO:1900048) | 3.34277400 |
| 134 | positive regulation of blood coagulation (GO:0030194) | 3.34277400 |
| 135 | glutamate metabolic process (GO:0006536) | 3.33833212 |
| 136 | negative regulation of lipid storage (GO:0010888) | 3.32572645 |
| 137 | negative regulation of lipase activity (GO:0060192) | 3.32365853 |
| 138 | regulation of plasminogen activation (GO:0010755) | 3.30524038 |
| 139 | epoxygenase P450 pathway (GO:0019373) | 3.30450268 |
| 140 | serine family amino acid metabolic process (GO:0009069) | 3.29211324 |
| 141 | cellular response to lipopolysaccharide (GO:0071222) | 3.28421633 |
| 142 | immunoglobulin mediated immune response (GO:0016064) | 3.27485522 |
| 143 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.27399622 |
| 144 | regulation of cholesterol storage (GO:0010885) | 3.26767206 |
| 145 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.26507373 |
| 146 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.24888509 |
| 147 | positive regulation of coagulation (GO:0050820) | 3.24687232 |
| 148 | regulation of immunoglobulin secretion (GO:0051023) | 3.22967387 |
| 149 | defense response to protozoan (GO:0042832) | 3.16093852 |
| 150 | activation of MAPKKK activity (GO:0000185) | 3.16084136 |
| 151 | cellular response to molecule of bacterial origin (GO:0071219) | 3.15254842 |
| 152 | myeloid dendritic cell activation (GO:0001773) | 3.15048992 |
| 153 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.12277365 |
| 154 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.09784561 |
| 155 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.09077473 |
| 156 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.08135499 |
| 157 | positive regulation of interleukin-6 production (GO:0032755) | 3.05725336 |
| 158 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.05450929 |
| 159 | adhesion of symbiont to host (GO:0044406) | 3.04795200 |
| 160 | negative regulation of amino acid transport (GO:0051956) | 3.02821054 |
| 161 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.02060343 |
| 162 | positive regulation of acute inflammatory response (GO:0002675) | 3.00365389 |
| 163 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.99229890 |
| 164 | eosinophil chemotaxis (GO:0048245) | 2.99110876 |
| 165 | ceramide catabolic process (GO:0046514) | 2.97147847 |
| 166 | regulation of interleukin-12 production (GO:0032655) | 2.96846680 |
| 167 | membrane lipid catabolic process (GO:0046466) | 2.95170595 |
| 168 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.94394115 |
| 169 | dendritic cell differentiation (GO:0097028) | 2.94076211 |
| 170 | granulocyte activation (GO:0036230) | 2.92144416 |
| 171 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.91557265 |
| 172 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90417595 |
| 173 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.90121969 |
| 174 | positive regulation of type 2 immune response (GO:0002830) | 2.90115190 |
| 175 | response to muramyl dipeptide (GO:0032495) | 2.85307788 |
| 176 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.84859406 |
| 177 | positive regulation of interferon-alpha production (GO:0032727) | 2.83383348 |
| 178 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.82771016 |
| 179 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.81617164 |
| 180 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.77909945 |
| 181 | sphingolipid catabolic process (GO:0030149) | 2.76796681 |
| 182 | negative regulation of growth of symbiont in host (GO:0044130) | 2.74148211 |
| 183 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.74148211 |
| 184 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.74148211 |
| 185 | regulation of growth of symbiont in host (GO:0044126) | 2.74148211 |
| 186 | cellular response to nicotine (GO:0071316) | 2.72345790 |
| 187 | amino sugar catabolic process (GO:0046348) | 2.72156317 |
| 188 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.71107251 |
| 189 | cellular response to biotic stimulus (GO:0071216) | 2.70055785 |
| 190 | decidualization (GO:0046697) | 2.68668990 |
| 191 | regulation of interleukin-6 production (GO:0032675) | 2.68600469 |
| 192 | mature B cell differentiation involved in immune response (GO:0002313) | 2.68379961 |
| 193 | response to thyroid hormone (GO:0097066) | 2.66399563 |
| 194 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.64922983 |
| 195 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.64676118 |
| 196 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.64108587 |
| 197 | regulation of type 2 immune response (GO:0002828) | 2.63911261 |
| 198 | eosinophil migration (GO:0072677) | 2.62862260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.95586839 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.16097995 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.12634111 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.99386033 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.72085690 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.16116980 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.50143446 |
| 8 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.17922950 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.50262575 |
| 10 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.11856205 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.02085789 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.58822877 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.53556385 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.53088952 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.45130440 |
| 16 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.33402883 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.26751178 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.20488331 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.99496171 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.92206105 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91703645 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.90301316 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.88518753 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.75777136 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.75581822 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.74516740 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73923296 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.69118835 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68015400 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.64010550 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63084667 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.61461353 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.61310760 |
| 34 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.58968096 |
| 35 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58074716 |
| 36 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.58050108 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55538213 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.55252981 |
| 39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.53897259 |
| 40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.53356001 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.53197598 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50294280 |
| 43 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49416895 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48665536 |
| 45 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.47722458 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.45879034 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43949633 |
| 48 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42629887 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41560347 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38011456 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.37441451 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.36359874 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36259807 |
| 54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34094463 |
| 55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34094463 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33907313 |
| 57 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.27982950 |
| 58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25760342 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25209843 |
| 60 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24363862 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.17360281 |
| 62 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.16407476 |
| 63 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14381216 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13141785 |
| 65 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.13093750 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10248168 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09821029 |
| 68 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09314716 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06283137 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03704801 |
| 71 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03651396 |
| 72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03063562 |
| 73 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02665391 |
| 74 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.02571895 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01195044 |
| 76 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99182722 |
| 77 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.98086147 |
| 78 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97723166 |
| 79 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.97443657 |
| 80 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.97443657 |
| 81 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.97443657 |
| 82 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.95331544 |
| 83 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94069558 |
| 84 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93558788 |
| 85 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92334190 |
| 86 | MYB_26560356_Chip-Seq_TH2_Human | 0.92100863 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91939840 |
| 88 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.91245741 |
| 89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89135818 |
| 90 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86945794 |
| 91 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86795647 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86203903 |
| 93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85997458 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85454389 |
| 95 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.84758986 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84526896 |
| 97 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.84291083 |
| 98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83774984 |
| 99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83559357 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82611118 |
| 101 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82152065 |
| 102 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81496385 |
| 103 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81135149 |
| 104 | UTX_26944678_Chip-Seq_JUKART_Human | 0.80796838 |
| 105 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.80307040 |
| 106 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.79595781 |
| 107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.79516199 |
| 108 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.79195744 |
| 109 | MAF_26560356_Chip-Seq_TH2_Human | 0.77290015 |
| 110 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.76664658 |
| 111 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.76401833 |
| 112 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75023756 |
| 113 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.74959241 |
| 114 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73088018 |
| 115 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70966014 |
| 116 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.69367893 |
| 117 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.68092470 |
| 118 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.66684771 |
| 119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64356132 |
| 120 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.62534569 |
| 121 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61408237 |
| 122 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.59479747 |
| 123 | GATA2_19941826_ChIP-Seq_K562_Human | 0.58646077 |
| 124 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.58472948 |
| 125 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.57985755 |
| 126 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.57839881 |
| 127 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.57568955 |
| 128 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.56557897 |
| 129 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55201227 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.53689439 |
| 131 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.53549101 |
| 132 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.52552893 |
| 133 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.52075544 |
| 134 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.51962634 |
| 135 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.51920246 |
| 136 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.51116036 |
| 137 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.51004424 |
| 138 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.50750597 |
| 139 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.50690732 |
| 140 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.50445403 |
| 141 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50043992 |
| 142 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.48798002 |
| 143 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.48704470 |
| 144 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.47909322 |
| 145 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.47360992 |
| 146 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.47274046 |
| 147 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.46930403 |
| 148 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.46402949 |
| 149 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.45724018 |
| 150 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.45216253 |
| 151 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44032729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.89085260 |
| 2 | MP0005360_urolithiasis | 6.25271044 |
| 3 | MP0005365_abnormal_bile_salt | 5.09150834 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.08440457 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.15445477 |
| 6 | MP0004510_myositis | 3.49708303 |
| 7 | MP0003252_abnormal_bile_duct | 3.39017791 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.34252884 |
| 9 | MP0009840_abnormal_foam_cell | 3.27579113 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.26229741 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.82657154 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.57321214 |
| 13 | MP0005083_abnormal_biliary_tract | 2.55282070 |
| 14 | MP0003195_calcinosis | 2.50853607 |
| 15 | MP0005671_abnormal_response_to | 2.33685964 |
| 16 | MP0005332_abnormal_amino_acid | 2.27217184 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.10461732 |
| 18 | MP0006054_spinal_hemorrhage | 2.08967681 |
| 19 | MP0000609_abnormal_liver_physiology | 2.06195049 |
| 20 | MP0008004_abnormal_stomach_pH | 2.04438538 |
| 21 | MP0005167_abnormal_blood-brain_barrier | 2.03929803 |
| 22 | MP0009278_abnormal_bone_marrow | 2.03491931 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.98543620 |
| 24 | MP0001666_abnormal_nutrient_absorption | 1.96886057 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.95930006 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.88564378 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.83720079 |
| 28 | MP0002723_abnormal_immune_serum | 1.83552255 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.74832414 |
| 30 | MP0003448_altered_tumor_morphology | 1.69989181 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.69800124 |
| 32 | MP0001800_abnormal_humoral_immune | 1.67807132 |
| 33 | MP0003436_decreased_susceptibility_to | 1.61595298 |
| 34 | MP0002332_abnormal_exercise_endurance | 1.61506527 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.59622421 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.59622421 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.56116770 |
| 38 | MP0002405_respiratory_system_inflammati | 1.50313228 |
| 39 | MP0003724_increased_susceptibility_to | 1.49095123 |
| 40 | MP0009764_decreased_sensitivity_to | 1.48575429 |
| 41 | MP0005310_abnormal_salivary_gland | 1.44939280 |
| 42 | MP0001819_abnormal_immune_cell | 1.44477117 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.44186739 |
| 44 | MP0003011_delayed_dark_adaptation | 1.42294505 |
| 45 | MP0005451_abnormal_body_composition | 1.42002927 |
| 46 | MP0003186_abnormal_redox_activity | 1.41814939 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.40606163 |
| 48 | MP0005275_abnormal_skin_tensile | 1.38533891 |
| 49 | MP0002254_reproductive_system_inflammat | 1.35507127 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.34247724 |
| 51 | MP0000685_abnormal_immune_system | 1.34130041 |
| 52 | MP0009697_abnormal_copulation | 1.34072759 |
| 53 | MP0003868_abnormal_feces_composition | 1.32560798 |
| 54 | MP0000604_amyloidosis | 1.29564429 |
| 55 | MP0005670_abnormal_white_adipose | 1.28913299 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.27404350 |
| 57 | MP0000858_altered_metastatic_potential | 1.26375627 |
| 58 | MP0006082_CNS_inflammation | 1.25995446 |
| 59 | MP0001764_abnormal_homeostasis | 1.25437254 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.23587098 |
| 61 | MP0003690_abnormal_glial_cell | 1.20778804 |
| 62 | MP0008469_abnormal_protein_level | 1.19146320 |
| 63 | MP0009763_increased_sensitivity_to | 1.18961048 |
| 64 | MP0010368_abnormal_lymphatic_system | 1.16880241 |
| 65 | MP0000598_abnormal_liver_morphology | 1.16440994 |
| 66 | MP0004130_abnormal_muscle_cell | 1.08651732 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.08098139 |
| 68 | MP0003091_abnormal_cell_migration | 1.06885076 |
| 69 | MP0002419_abnormal_innate_immunity | 1.06763509 |
| 70 | MP0005464_abnormal_platelet_physiology | 1.02315973 |
| 71 | MP0003303_peritoneal_inflammation | 1.02039651 |
| 72 | MP0005390_skeleton_phenotype | 1.01510682 |
| 73 | MP0003329_amyloid_beta_deposits | 0.98932981 |
| 74 | MP0000716_abnormal_immune_system | 0.98597304 |
| 75 | MP0005647_abnormal_sex_gland | 0.98549939 |
| 76 | MP0000920_abnormal_myelination | 0.97785551 |
| 77 | MP0005165_increased_susceptibility_to | 0.97741002 |
| 78 | MP0001835_abnormal_antigen_presentation | 0.95542276 |
| 79 | MP0001533_abnormal_skeleton_physiology | 0.93678280 |
| 80 | MP0009785_altered_susceptibility_to | 0.92761120 |
| 81 | MP0002971_abnormal_brown_adipose | 0.92273024 |
| 82 | MP0005408_hypopigmentation | 0.87288776 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 0.86220087 |
| 84 | MP0002060_abnormal_skin_morphology | 0.85836786 |
| 85 | MP0003075_altered_response_to | 0.85111072 |
| 86 | MP0001501_abnormal_sleep_pattern | 0.84098743 |
| 87 | MP0005595_abnormal_vascular_smooth | 0.84046665 |
| 88 | MP0005503_abnormal_tendon_morphology | 0.83796428 |
| 89 | MP0005025_abnormal_response_to | 0.81611420 |
| 90 | MP0002933_joint_inflammation | 0.80966722 |
| 91 | MP0009642_abnormal_blood_homeostasis | 0.80470137 |
| 92 | * MP0005334_abnormal_fat_pad | 0.80445227 |
| 93 | MP0005164_abnormal_response_to | 0.80061458 |
| 94 | MP0001663_abnormal_digestive_system | 0.78994751 |
| 95 | MP0001661_extended_life_span | 0.76317391 |
| 96 | MP0005257_abnormal_intraocular_pressure | 0.75853077 |
| 97 | MP0005166_decreased_susceptibility_to | 0.75771949 |
| 98 | MP0003279_aneurysm | 0.75361333 |
| 99 | MP0003795_abnormal_bone_structure | 0.74178152 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.74051407 |
| 101 | MP0000343_altered_response_to | 0.73627513 |
| 102 | MP0005023_abnormal_wound_healing | 0.72981793 |
| 103 | MP0001845_abnormal_inflammatory_respons | 0.72599137 |
| 104 | MP0002837_dystrophic_cardiac_calcinosis | 0.71966724 |
| 105 | MP0002429_abnormal_blood_cell | 0.71545153 |
| 106 | MP0002398_abnormal_bone_marrow | 0.71326686 |
| 107 | MP0003646_muscle_fatigue | 0.71255570 |
| 108 | MP0008874_decreased_physiological_sensi | 0.70204331 |
| 109 | MP0002295_abnormal_pulmonary_circulatio | 0.70081053 |
| 110 | MP0010307_abnormal_tumor_latency | 0.69341178 |
| 111 | MP0001853_heart_inflammation | 0.68772500 |
| 112 | MP0005376_homeostasis/metabolism_phenot | 0.68651063 |
| 113 | MP0003950_abnormal_plasma_membrane | 0.67921934 |
| 114 | MP0004883_abnormal_blood_vessel | 0.65936789 |
| 115 | MP0001243_abnormal_dermal_layer | 0.65899684 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.65860593 |
| 117 | MP0000249_abnormal_blood_vessel | 0.65776042 |
| 118 | MP0002877_abnormal_melanocyte_morpholog | 0.65187423 |
| 119 | MP0005636_abnormal_mineral_homeostasis | 0.64978247 |
| 120 | MP0005076_abnormal_cell_differentiation | 0.64956478 |
| 121 | MP0003828_pulmonary_edema | 0.64600184 |
| 122 | MP0000689_abnormal_spleen_morphology | 0.63265284 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.62242435 |
| 124 | MP0005535_abnormal_body_temperature | 0.62084249 |
| 125 | MP0002876_abnormal_thyroid_physiology | 0.62057742 |
| 126 | MP0004808_abnormal_hematopoietic_stem | 0.61809621 |
| 127 | MP0002168_other_aberrant_phenotype | 0.61730740 |
| 128 | MP0002998_abnormal_bone_remodeling | 0.61584165 |
| 129 | MP0001756_abnormal_urination | 0.60012699 |
| 130 | MP0004947_skin_inflammation | 0.59577538 |
| 131 | MP0002148_abnormal_hypersensitivity_rea | 0.59401074 |
| 132 | MP0004185_abnormal_adipocyte_glucose | 0.58775943 |
| 133 | MP0009053_abnormal_anal_canal | 0.58356128 |
| 134 | MP0010352_gastrointestinal_tract_polyps | 0.58246733 |
| 135 | MP0003634_abnormal_glial_cell | 0.58141669 |
| 136 | MP0001542_abnormal_bone_strength | 0.57797217 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.57787864 |
| 138 | MP0005084_abnormal_gallbladder_morpholo | 0.57604136 |
| 139 | * MP0009115_abnormal_fat_cell | 0.57594214 |
| 140 | MP0005000_abnormal_immune_tolerance | 0.57126580 |
| 141 | MP0002722_abnormal_immune_system | 0.56326936 |
| 142 | MP0003453_abnormal_keratinocyte_physiol | 0.55718017 |
| 143 | MP0003300_gastrointestinal_ulcer | 0.55227116 |
| 144 | MP0001881_abnormal_mammary_gland | 0.53366080 |
| 145 | MP0001790_abnormal_immune_system | 0.53164708 |
| 146 | MP0005387_immune_system_phenotype | 0.53164708 |
| 147 | MP0005220_abnormal_exocrine_pancreas | 0.52911361 |
| 148 | MP0005248_abnormal_Harderian_gland | 0.52677365 |
| 149 | MP0001727_abnormal_embryo_implantation | 0.51223441 |
| 150 | MP0001851_eye_inflammation | 0.51124165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 7.93424068 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.93424068 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.93424068 |
| 4 | Deep venous thrombosis (HP:0002625) | 6.74426847 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 6.20610120 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.97901837 |
| 7 | Xanthomatosis (HP:0000991) | 5.87063716 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 5.85817293 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.67645567 |
| 10 | Complement deficiency (HP:0004431) | 5.43178237 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 5.11971094 |
| 12 | Joint hemorrhage (HP:0005261) | 5.11088236 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 5.05596314 |
| 14 | Disinhibition (HP:0000734) | 4.87211122 |
| 15 | Loss of speech (HP:0002371) | 4.84252223 |
| 16 | Dysostosis multiplex (HP:0000943) | 4.83065550 |
| 17 | Abnormality of macrophages (HP:0004311) | 4.53414497 |
| 18 | Nuclear cataract (HP:0100018) | 4.31167961 |
| 19 | Mutism (HP:0002300) | 4.27103341 |
| 20 | Epidermoid cyst (HP:0200040) | 4.27028868 |
| 21 | Optic neuritis (HP:0100653) | 4.26733765 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 4.26733765 |
| 23 | Orchitis (HP:0100796) | 4.24467377 |
| 24 | Abnormality of complement system (HP:0005339) | 4.22359321 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 4.20825318 |
| 26 | Hypolipoproteinemia (HP:0010981) | 4.17290677 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.09535062 |
| 28 | Myocardial infarction (HP:0001658) | 4.04548203 |
| 29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.03869403 |
| 30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.02124308 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 4.01512484 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 3.91578525 |
| 33 | Neurofibrillary tangles (HP:0002185) | 3.88143253 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.86289813 |
| 35 | Hyperammonemia (HP:0001987) | 3.81739485 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 3.81500881 |
| 37 | Stomatitis (HP:0010280) | 3.80956776 |
| 38 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.75395269 |
| 39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.75395269 |
| 40 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.75395269 |
| 41 | Myositis (HP:0100614) | 3.71734144 |
| 42 | Hypercholesterolemia (HP:0003124) | 3.69212652 |
| 43 | Fat malabsorption (HP:0002630) | 3.67108483 |
| 44 | Hyperglycinemia (HP:0002154) | 3.56826876 |
| 45 | Mucopolysacchariduria (HP:0008155) | 3.51073076 |
| 46 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.51073076 |
| 47 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.47281795 |
| 48 | Abnormality of methionine metabolism (HP:0010901) | 3.43060669 |
| 49 | Abnormality of the intrinsic pathway (HP:0010989) | 3.39689607 |
| 50 | Ketosis (HP:0001946) | 3.39319240 |
| 51 | Hyperglycinuria (HP:0003108) | 3.35182336 |
| 52 | Recurrent abscess formation (HP:0002722) | 3.33565941 |
| 53 | Hypoglycemic coma (HP:0001325) | 3.30422735 |
| 54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.29517395 |
| 55 | Abnormality of glycine metabolism (HP:0010895) | 3.29517395 |
| 56 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.27362650 |
| 57 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.23359531 |
| 58 | Apathy (HP:0000741) | 3.14985378 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 3.13024323 |
| 60 | Conjugated hyperbilirubinemia (HP:0002908) | 3.11774838 |
| 61 | Skin nodule (HP:0200036) | 3.06812712 |
| 62 | Interstitial pulmonary disease (HP:0006530) | 3.05750443 |
| 63 | Diminished motivation (HP:0000745) | 3.03253144 |
| 64 | Glomerulonephritis (HP:0000099) | 2.97620136 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.97111391 |
| 66 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.91299775 |
| 67 | Steatorrhea (HP:0002570) | 2.90088192 |
| 68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.86449534 |
| 69 | Hepatocellular carcinoma (HP:0001402) | 2.85373953 |
| 70 | Hematochezia (HP:0002573) | 2.83170646 |
| 71 | Mitral stenosis (HP:0001718) | 2.78545168 |
| 72 | Inappropriate behavior (HP:0000719) | 2.78051963 |
| 73 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.77921359 |
| 74 | Cerebral inclusion bodies (HP:0100314) | 2.77533352 |
| 75 | Metaphyseal irregularity (HP:0003025) | 2.75489818 |
| 76 | Keratoconjunctivitis (HP:0001096) | 2.68917385 |
| 77 | Amyloidosis (HP:0011034) | 2.67126664 |
| 78 | Hyperbilirubinemia (HP:0002904) | 2.63905072 |
| 79 | Abnormality of nucleobase metabolism (HP:0010932) | 2.61063232 |
| 80 | Gingival bleeding (HP:0000225) | 2.60251140 |
| 81 | Spontaneous abortion (HP:0005268) | 2.60219052 |
| 82 | Neuronal loss in central nervous system (HP:0002529) | 2.57050523 |
| 83 | Pulmonary infiltrates (HP:0002113) | 2.53610062 |
| 84 | Progressive neurologic deterioration (HP:0002344) | 2.52391105 |
| 85 | Menorrhagia (HP:0000132) | 2.52338164 |
| 86 | Agnosia (HP:0010524) | 2.51864753 |
| 87 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.49973372 |
| 88 | Esophageal varix (HP:0002040) | 2.48697923 |
| 89 | Parakeratosis (HP:0001036) | 2.48430078 |
| 90 | Vascular calcification (HP:0004934) | 2.46012420 |
| 91 | Peritonitis (HP:0002586) | 2.45511661 |
| 92 | Cardiovascular calcification (HP:0011915) | 2.44882594 |
| 93 | Abnormality of serum amino acid levels (HP:0003112) | 2.43489044 |
| 94 | Hemorrhage of the eye (HP:0011885) | 2.38339602 |
| 95 | Prolonged neonatal jaundice (HP:0006579) | 2.35773410 |
| 96 | Gangrene (HP:0100758) | 2.33989323 |
| 97 | Delayed CNS myelination (HP:0002188) | 2.32712656 |
| 98 | Ketoacidosis (HP:0001993) | 2.32201952 |
| 99 | Nephritis (HP:0000123) | 2.31337115 |
| 100 | Abnormality of purine metabolism (HP:0004352) | 2.29915082 |
| 101 | Basal ganglia calcification (HP:0002135) | 2.28960905 |
| 102 | Hydroxyprolinuria (HP:0003080) | 2.26298933 |
| 103 | Abnormality of proline metabolism (HP:0010907) | 2.26298933 |
| 104 | Axonal loss (HP:0003447) | 2.25854887 |
| 105 | Polyneuropathy (HP:0001271) | 2.25701245 |
| 106 | Increased IgM level (HP:0003496) | 2.25519523 |
| 107 | Asymmetric septal hypertrophy (HP:0001670) | 2.24075538 |
| 108 | Vacuolated lymphocytes (HP:0001922) | 2.22396738 |
| 109 | Hypochromic microcytic anemia (HP:0004840) | 2.16693284 |
| 110 | Hepatosplenomegaly (HP:0001433) | 2.16080522 |
| 111 | Nausea (HP:0002018) | 2.15776311 |
| 112 | Dementia (HP:0000726) | 2.15625144 |
| 113 | Metabolic acidosis (HP:0001942) | 2.15410350 |
| 114 | Vasculitis (HP:0002633) | 2.15406166 |
| 115 | Spastic diplegia (HP:0001264) | 2.12827654 |
| 116 | Hemoptysis (HP:0002105) | 2.12233175 |
| 117 | Pancreatitis (HP:0001733) | 2.10860088 |
| 118 | Personality changes (HP:0000751) | 2.10160377 |
| 119 | Sensorimotor neuropathy (HP:0007141) | 2.09379004 |
| 120 | Abnormality of iron homeostasis (HP:0011031) | 2.08363626 |
| 121 | Hypoglycemic seizures (HP:0002173) | 2.08084288 |
| 122 | Eczematoid dermatitis (HP:0000976) | 2.07452340 |
| 123 | Thrombophlebitis (HP:0004418) | 2.07227691 |
| 124 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.03001428 |
| 125 | Dicarboxylic aciduria (HP:0003215) | 2.03001428 |
| 126 | Petechiae (HP:0000967) | 2.01484130 |
| 127 | Hypertriglyceridemia (HP:0002155) | 1.97552033 |
| 128 | Abnormal gallbladder morphology (HP:0012437) | 1.97180681 |
| 129 | Pulmonary embolism (HP:0002204) | 1.96531870 |
| 130 | Thin bony cortex (HP:0002753) | 1.95258974 |
| 131 | Peripheral demyelination (HP:0011096) | 1.94981395 |
| 132 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93328023 |
| 133 | Cholelithiasis (HP:0001081) | 1.92780289 |
| 134 | Abnormal cartilage morphology (HP:0002763) | 1.91662519 |
| 135 | Bone pain (HP:0002653) | 1.90142260 |
| 136 | Obstructive lung disease (HP:0006536) | 1.89499663 |
| 137 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89499663 |
| 138 | Memory impairment (HP:0002354) | 1.88572497 |
| 139 | Lethargy (HP:0001254) | 1.88249680 |
| 140 | Supranuclear gaze palsy (HP:0000605) | 1.87548197 |
| 141 | Recurrent viral infections (HP:0004429) | 1.87517952 |
| 142 | Pathologic fracture (HP:0002756) | 1.86122905 |
| 143 | Upper motor neuron abnormality (HP:0002127) | 1.85095437 |
| 144 | Acanthocytosis (HP:0001927) | 1.84883523 |
| 145 | Hypergammaglobulinemia (HP:0010702) | 1.84559545 |
| 146 | Increased serum ferritin (HP:0003281) | 1.83691022 |
| 147 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.83463113 |
| 148 | Recurrent bacterial skin infections (HP:0005406) | 1.82740108 |
| 149 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.82599277 |
| 150 | Increased mean platelet volume (HP:0011877) | 1.82183555 |
| 151 | Neonatal onset (HP:0003623) | 1.81604963 |
| 152 | Irritability (HP:0000737) | 1.80819682 |
| 153 | Purpura (HP:0000979) | 1.80643253 |
| 154 | Vertigo (HP:0002321) | 1.80360584 |
| 155 | Hypophosphatemic rickets (HP:0004912) | 1.80218280 |
| 156 | Mesangial abnormality (HP:0001966) | 1.80024538 |
| 157 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79139455 |
| 158 | Protrusio acetabuli (HP:0003179) | 1.78818098 |
| 159 | Opisthotonus (HP:0002179) | 1.78680545 |
| 160 | Acne (HP:0001061) | 1.78075524 |
| 161 | T lymphocytopenia (HP:0005403) | 1.78019720 |
| 162 | Zonular cataract (HP:0010920) | 1.77674041 |
| 163 | Arterial thrombosis (HP:0004420) | 1.77661144 |
| 164 | Vertebral compression fractures (HP:0002953) | 1.76181907 |
| 165 | Gingivitis (HP:0000230) | 1.74465569 |
| 166 | Recurrent skin infections (HP:0001581) | 1.74422173 |
| 167 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.73887433 |
| 168 | Conjunctival telangiectasia (HP:0000524) | 1.73198645 |
| 169 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.72681010 |
| 170 | Thoracic kyphosis (HP:0002942) | 1.72669430 |
| 171 | Increased CSF protein (HP:0002922) | 1.72247062 |
| 172 | Abnormality of the pericardium (HP:0001697) | 1.72172149 |
| 173 | Autoimmune hemolytic anemia (HP:0001890) | 1.71993361 |
| 174 | Premature rupture of membranes (HP:0001788) | 1.70735250 |
| 175 | Elevated alkaline phosphatase (HP:0003155) | 1.69743233 |
| 176 | Malnutrition (HP:0004395) | 1.68825705 |
| 177 | Increased cerebral lipofuscin (HP:0011813) | 1.68671684 |
| 178 | Vomiting (HP:0002013) | 1.68629692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.38279086 |
| 2 | BCKDK | 3.97528689 |
| 3 | GRK7 | 3.87219096 |
| 4 | SIK1 | 3.61668255 |
| 5 | TAOK2 | 3.37360954 |
| 6 | FGFR4 | 3.36453218 |
| 7 | TAOK3 | 2.61896547 |
| 8 | MATK | 2.52150709 |
| 9 | TYK2 | 2.38402769 |
| 10 | TAOK1 | 2.37960269 |
| 11 | MST1R | 2.34474872 |
| 12 | ERBB4 | 2.34083970 |
| 13 | TRIB3 | 2.29917943 |
| 14 | INSRR | 2.22577334 |
| 15 | MAP3K14 | 2.18814945 |
| 16 | MOS | 2.07692013 |
| 17 | IRAK3 | 2.02754423 |
| 18 | PBK | 2.01828124 |
| 19 | TBK1 | 2.01586788 |
| 20 | ABL2 | 2.01090794 |
| 21 | NEK9 | 1.89275616 |
| 22 | PIK3CG | 1.86540957 |
| 23 | PKN2 | 1.84725562 |
| 24 | PRPF4B | 1.82873787 |
| 25 | JAK1 | 1.77663567 |
| 26 | EPHB1 | 1.76622754 |
| 27 | CDC42BPA | 1.70073796 |
| 28 | EPHA3 | 1.69448464 |
| 29 | ADRBK2 | 1.67868956 |
| 30 | TGFBR2 | 1.67177586 |
| 31 | LATS1 | 1.55982542 |
| 32 | BLK | 1.55740788 |
| 33 | FLT3 | 1.51142385 |
| 34 | KIT | 1.49492551 |
| 35 | ACVR1B | 1.49076678 |
| 36 | BMPR2 | 1.43663103 |
| 37 | CAMK1D | 1.42685859 |
| 38 | FRK | 1.40251625 |
| 39 | TXK | 1.38247618 |
| 40 | PTK6 | 1.36598904 |
| 41 | JAK2 | 1.34792781 |
| 42 | CSK | 1.24053936 |
| 43 | FGFR3 | 1.21461202 |
| 44 | MET | 1.17335668 |
| 45 | BMX | 1.14841556 |
| 46 | TYRO3 | 1.12780320 |
| 47 | RIPK1 | 1.10097182 |
| 48 | FGFR2 | 1.08286016 |
| 49 | MAPK11 | 1.07781810 |
| 50 | PDGFRA | 1.07337718 |
| 51 | IKBKE | 1.05803864 |
| 52 | MAP3K1 | 1.05525742 |
| 53 | MAP2K3 | 1.05225989 |
| 54 | MAP3K5 | 1.04984340 |
| 55 | IKBKB | 1.01835006 |
| 56 | CDK6 | 1.00352019 |
| 57 | IRAK4 | 0.99164166 |
| 58 | MAP3K10 | 0.99032343 |
| 59 | CSF1R | 0.98846780 |
| 60 | CLK1 | 0.90861494 |
| 61 | MAP2K4 | 0.89549751 |
| 62 | JAK3 | 0.85619974 |
| 63 | IRAK1 | 0.83734051 |
| 64 | TRPM7 | 0.80628273 |
| 65 | PRKAA2 | 0.80412576 |
| 66 | DDR2 | 0.76636102 |
| 67 | STK3 | 0.76599993 |
| 68 | TESK1 | 0.75039403 |
| 69 | MAP3K3 | 0.73119189 |
| 70 | MAP4K1 | 0.70224376 |
| 71 | STK10 | 0.69170454 |
| 72 | EPHB2 | 0.68952157 |
| 73 | MAP2K6 | 0.67904190 |
| 74 | CHUK | 0.67878584 |
| 75 | GSK3A | 0.67551868 |
| 76 | DAPK2 | 0.66890944 |
| 77 | MAPK4 | 0.66795955 |
| 78 | CAMK1G | 0.66086778 |
| 79 | SYK | 0.65965480 |
| 80 | MARK3 | 0.65683749 |
| 81 | RIPK4 | 0.65632937 |
| 82 | KDR | 0.65392442 |
| 83 | TTN | 0.65222691 |
| 84 | ABL1 | 0.64744716 |
| 85 | ERBB2 | 0.61349623 |
| 86 | DYRK3 | 0.60534841 |
| 87 | STK38L | 0.59326339 |
| 88 | IGF1R | 0.57041002 |
| 89 | ZAP70 | 0.55564827 |
| 90 | LCK | 0.54836796 |
| 91 | PRKCZ | 0.51853809 |
| 92 | HCK | 0.51806452 |
| 93 | PDGFRB | 0.51684842 |
| 94 | MAPK12 | 0.51236014 |
| 95 | PRKCH | 0.51085672 |
| 96 | PRKACG | 0.50425509 |
| 97 | EGFR | 0.50109920 |
| 98 | LYN | 0.50061798 |
| 99 | CAMKK2 | 0.50035551 |
| 100 | ARAF | 0.49324505 |
| 101 | TIE1 | 0.48964708 |
| 102 | PIK3CA | 0.48739481 |
| 103 | PAK4 | 0.48593121 |
| 104 | NME2 | 0.48131373 |
| 105 | TESK2 | 0.47470919 |
| 106 | MAP3K11 | 0.47028780 |
| 107 | PDPK1 | 0.46628899 |
| 108 | PTK2 | 0.46200908 |
| 109 | ICK | 0.45709026 |
| 110 | MAPK7 | 0.45132758 |
| 111 | LATS2 | 0.45071769 |
| 112 | PKN1 | 0.43708885 |
| 113 | RPS6KA4 | 0.42596987 |
| 114 | RPS6KC1 | 0.41813209 |
| 115 | RPS6KL1 | 0.41813209 |
| 116 | MAP2K1 | 0.40980171 |
| 117 | PRKCQ | 0.40714025 |
| 118 | DAPK3 | 0.40173982 |
| 119 | SGK3 | 0.39240904 |
| 120 | MAP3K13 | 0.38924592 |
| 121 | PIM1 | 0.38809108 |
| 122 | SIK3 | 0.38297020 |
| 123 | LRRK2 | 0.37720295 |
| 124 | IRAK2 | 0.36731821 |
| 125 | HIPK2 | 0.35888848 |
| 126 | DYRK1B | 0.35248590 |
| 127 | PIM2 | 0.34785529 |
| 128 | STK4 | 0.33745461 |
| 129 | RPS6KA6 | 0.32865278 |
| 130 | INSR | 0.31378550 |
| 131 | FER | 0.31086047 |
| 132 | FGR | 0.30561847 |
| 133 | PRKCD | 0.30349092 |
| 134 | RET | 0.30258349 |
| 135 | BTK | 0.29087708 |
| 136 | STK24 | 0.27517051 |
| 137 | LIMK1 | 0.24550978 |
| 138 | RPS6KA2 | 0.20731989 |
| 139 | MAPKAPK2 | 0.18185058 |
| 140 | MAPK15 | 0.18094268 |
| 141 | CDK14 | 0.17596098 |
| 142 | CDK15 | 0.16301730 |
| 143 | PDK1 | 0.15401972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 8.95358665 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.39125180 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.44196372 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.20889489 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.19538004 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.93480747 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.87343472 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.58349025 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.57834680 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.51098804 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.50156052 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48185183 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.38784783 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.34196135 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.30942025 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.30746216 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.28380521 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.26531327 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.14777495 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.10576275 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 2.04453147 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.01949250 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.98749985 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.96842876 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.92517100 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92280148 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.91468949 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86830714 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.85818675 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85712751 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83835602 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81046732 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.80791449 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78604380 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76862672 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.75636058 |
| 37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.72184641 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68318276 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.64267124 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.59568970 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56237857 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.55362424 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.55082985 |
| 44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.47083280 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46981997 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.42186065 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.39067577 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.38257562 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.37759534 |
| 50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34593679 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31839322 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28449302 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.28118760 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 1.27617900 |
| 55 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27032926 |
| 56 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25866969 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21689391 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20336117 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.20071941 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 1.16496124 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 1.14661126 |
| 62 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13875296 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13105093 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11745532 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11021887 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09375124 |
| 67 | Measles_Homo sapiens_hsa05162 | 1.06339728 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04736571 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04048263 |
| 70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03273736 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03242512 |
| 72 | Shigellosis_Homo sapiens_hsa05131 | 1.02896600 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98555781 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.98188761 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95451403 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.95371312 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94197812 |
| 78 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.93901935 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93305135 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91970373 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.91700220 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88948587 |
| 83 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87217875 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.84625966 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83464692 |
| 86 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79080901 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79076649 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.77886868 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76256276 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.75811743 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73816716 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72662438 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69853402 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69467440 |
| 95 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68673968 |
| 96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68082229 |
| 97 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67753609 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67424331 |
| 99 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65314779 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62754927 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62268661 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61428616 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61170346 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60670286 |
| 105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60061890 |
| 106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56223845 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55677994 |
| 108 | Malaria_Homo sapiens_hsa05144 | 0.53563228 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53284228 |
| 110 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52958861 |
| 111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51787346 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.50846629 |
| 113 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50602579 |
| 114 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.48525283 |
| 115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48473896 |
| 116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48333125 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46613307 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.44826303 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43019393 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40854135 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.38144558 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37963471 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37629851 |
| 124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35266121 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32778582 |
| 126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31431486 |
| 127 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31087504 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.28441468 |
| 129 | Pertussis_Homo sapiens_hsa05133 | 0.28118212 |
| 130 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26586310 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.26233644 |
| 132 | Leishmaniasis_Homo sapiens_hsa05140 | 0.23518482 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22446306 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.21964966 |
| 135 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.20765068 |
| 136 | Legionellosis_Homo sapiens_hsa05134 | 0.20751053 |
| 137 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20092941 |
| 138 | Amoebiasis_Homo sapiens_hsa05146 | 0.19732351 |
| 139 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.19498879 |
| 140 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.18690275 |
| 141 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18317225 |
| 142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.18156857 |
| 143 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.17516042 |
| 144 | Other glycan degradation_Homo sapiens_hsa00511 | 0.17385209 |
| 145 | Tuberculosis_Homo sapiens_hsa05152 | 0.15862571 |
| 146 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.15038706 |
| 147 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14591077 |
| 148 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.14164354 |
| 149 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.13743843 |
| 150 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.13590015 |
| 151 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.12636186 |
| 152 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.12555079 |
| 153 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.11555865 |
| 154 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.11293823 |
| 155 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.10756519 |
| 156 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10480970 |
| 157 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.09019314 |
| 158 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.07205099 |
| 159 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.06833787 |
| 160 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.06096849 |
| 161 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05129778 |
| 162 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.05119984 |
| 163 | Hepatitis C_Homo sapiens_hsa05160 | 0.03175586 |
| 164 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.02398815 |
| 165 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.02041216 |
| 166 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.00459875 |
| 167 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0162124 |

